Gelteq Limited Ordinary Shares (GELS)
Automate Your Wheel Strategy on GELS
With Tiblio's Option Bot, you can configure your own wheel strategy including GELS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol GELS
- Rev/Share 0.0
- Book/Share 0.0
- PB 0.0
- Debt/Equity 0.2543
- CurrentRatio 0.0784
- ROIC -0.1552
- MktCap 21389326.4475
- FreeCF/Share 0.0
- PFCF -17.5518
- PE 0.0
- Debt/Assets 0.1852
- DivYield 0
- ROE -0.21
- Rating D+
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market
Published: September 05, 2025 by: GlobeNewsWire
Sentiment: Neutral
MELBOURNE, Australia, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based company specialising in gel-based oral delivery solutions, today announced plans to commence a preclinical bioequivalence study in September 2025 to evaluate its novel gel-based formulation of a widely used antihistamine for allergy treatment.
Read More
Healthy Extracts Reports Record Q2 2025 Net Revenue, Driving Positive EPS and EBITDA; Increases 2025 Net Revenue Guidance by 50%
Published: August 13, 2025 by: Accesswire
Sentiment: Neutral
Net Revenue Outlook for 2025 Increased from $4.2 Million+ to $6.3 Million+, Representing Growth of 102%+, Based on Recent Transformative Merger with Gummy USA LAS VEGAS, NV / ACCESS Newswire / August 13, 2025 / Healthy Extracts Inc. (OTCQB:HYEX), a leader in plant-based nutraceutical innovations, reported results for its second quarter and six months ended June 30, 2025. All comparisons are to the same year-ago period unless otherwise noted.
Read More
Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities
Published: July 17, 2025 by: GlobeNewsWire
Sentiment: Neutral
Partnership to support the scale-up and commercialization of Gelteq's proprietary gel-based oral delivery platform Partnership to support the scale-up and commercialization of Gelteq's proprietary gel-based oral delivery platform
Read More
Gelteq's Sportsgel Brand Named Official Sponsor of the Professional Pickleball Tour and League of Australia and New Zealand
Published: February 27, 2025 by: GlobeNewsWire
Sentiment: Neutral
Sportsgel signs first league-wide sports deal to be the official performance gel of the preeminent pickleball tour across the Oceania region Sportsgel signs first league-wide sports deal to be the official performance gel of the preeminent pickleball tour across the Oceania region
Read More
About Gelteq Limited Ordinary Shares (GELS)
- IPO Date
- Website https://www.gelteq.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Nathan Jacob Givoni
- Employees 7